While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

The DOJ has accused CHEST and other medical journals of scientific bias, demanding responses to a list of questions by May 2, 2025.

Children with atopic dermatitis are more likely to develop uveitis than children without it, especially if the dermatitis is severe.

The FDA expect to revoke authorization for Citrus Red No. 2 and Orange B in the next several months, followed by 6 additional dyes by the end of 2026. HealthDay News — The U.S. Department of Health ...

The US, Canada, and Mexico are already reporting a combined 2200 cases of the measles in the still-growing outbreak.

The Supreme Court will decide whether health insurance must cover preventive care services recommended by the USPSTF.

Treatment of acquired dermal melanocytosis with a 730-nm picosecond laser was superior to conventional treatment with a 1064-nm laser.

Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

A White House internal memo listed intended HHS budget cuts in addition to ongoing layoffs, particularly for the CDC and NIH.

The WHO's draft agreement, to be approved in May, emphasizes international coordination to improve pandemic preparedness.